Topical Hair Loss Composition for Efficacy With Fewer Scalp Reactions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current hair loss treatments, such as minoxidil and cyoctol, have limited efficacy and cause adverse dermatological reactions, require frequent application, and result in undesirable side effects like drying and irritation, failing to provide healthy-looking hair and scalp.
Innovation Solution
A topical formulation comprising therapeutically effective amounts of azelaic acid, minoxidil, finasteride, and dutasteride, optionally with caffeine and saw palmetto extract, to treat hair loss and promote hair growth, minimizing side effects and application frequency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If single agent formulations like minoxidil or cyoctol are used, then treatment simplicity is maintained, but efficacy is limited and adverse dermatological reactions occur
Solution Approach 1:
The patent combines multiple anti-alopecia agents (minoxidil, cyoctol, and other compounds) into a single topical formulation. This merging approach allows the composition to achieve synergistic effects that improve treatment efficacy while reducing the need for multiple separate applications, thereby minimizing adverse reactions associated with single high-dose agents.
Solution Approach 2:
The invention uses a composite formulation containing multiple active ingredients at optimized concentrations. This composite approach allows each agent to contribute its specific anti-alopecia mechanism while the overall composition achieves enhanced efficacy and reduced side effects compared to single agent formulations.
2Reliability
If conventional formulations are applied frequently to maintain efficacy, then treatment effectiveness is improved, but user frustration and error increase due to missed applications
Solution Approach 1:
The patent merges multiple anti-alopecia agents into a single topical composition that can be applied once daily. This consolidation maintains treatment effectiveness by combining the effects of multiple agents while simplifying the application regimen, thereby reducing user frustration and missed applications associated with frequent separate treatments.
3Reliability
If conventional formulations are used to treat hair loss, then some hair growth promotion is achieved, but undesirable side effects occur including drying, frizzing, scalp itching, and extended wet hair time
Solution Approach 1:
The patent optimizes the concentration parameters of multiple active ingredients in the topical formulation. By carefully controlling the amounts of minoxidil, cyoctol, and other compounds, the composition achieves effective hair growth promotion while minimizing drying effects, frizzing, and scalp irritation. The formulation also incorporates ingredients that counteract undesirable cosmetic effects.
Solution Approach 2:
The invention uses a composite formulation that combines hair growth-promoting agents with ingredients that mitigate side effects. This multi-component composition achieves synergistic hair growth promotion while the included compounds counteract drying, frizzing, and irritation, providing both therapeutic benefit and cosmetic acceptability.
4Reliability
If potent anti-alopecia treatments are applied, then hair loss mitigation is improved, but the complexity of the treatment regimen increases
Solution Approach 1:
The patent merges multiple anti-alopecia agents into a single topical formulation that can be applied once daily. This consolidation maintains potent hair loss mitigation by combining the effects of multiple agents while simplifying the treatment regimen, thereby reducing the complexity of multiple separate applications and improving patient compliance.
Data Source
AI summary
In one aspect, the disclosure relates to topical formulations, methods of making same, and methods of treating hair loss using same. In an aspect, the present disclosure pertains to topical formulations for treatment of hair loss and/or to increase hair growth, the formulation comprising: a therapeutic composition comprising therapeutically effective amounts of azelaic acid, minoxidil, finasteride, and dutasteride; and one or more compounding agents. In a further aspect, the present disclosure pertains to a method of treating hair loss by applying a disclosed topical formulation. In a further aspect, the present disclosure pertains to a method of enhancing hair grow by applying a disclosed topical formulation. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.